The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 12, 2026
Filed:
Apr. 10, 2020
R.p. Scherer Technologies, Llc, Carson City, NV (US);
Pfizer Ireland Pharmaceuticals, Ringaskiddy, IE;
Vincent Plassat, La Ferté Alais, FR;
Benoit Hilbold, Schiltigheim, FR;
Aurélia Galus, Weyersheim, FR;
Thomas Pointeaux, Reichstett, FR;
Julien Meissonnier, Souffelweyersheim, FR;
Gene M. Dubowchik, New Haven, CT (US);
Charles M. Conway, New Haven, CT (US);
Rajesh Kumar, New Haven, CT (US);
R.P. Scherer Technologies, LLC, Carson City, NV (US);
Pfizer Ireland Pharmaceuticals, Ringaskiddy, IE;
Abstract
The present disclosure is directed to a pharmaceutical formulation intended for oral delivery of synthetic or natural poorly permeable calcitonin gene-related peptide (CGRP) inhibitors or salts/solvates thereof having a therapeutic activity. The pharmaceutical formulation can include a synthetic or natural poorly permeable CGRP inhibitors or salt or solvate thereof in an amount 0.01-10 wt. % of the total weight of the formulation; a lipophilic phase comprising triglycerides of fatty acids in an amount of 50-80 wt. % of the total weight of the formulation; and at least one lipophilic surfactant comprising partial esters of polyol and fatty acids in an amount of about 10-50 wt. % of the total weight of the formulation.